Back to Results
First PageMeta Content
Pharmacology / Medicine / Fenfluramine/phentermine / Wyeth / Dexfenfluramine / Health / Fenfluramine / Phentermine / Anorectics / Amphetamines / Organofluorides


Microsoft Word - STEMPLER OPINION.doc
Add to Reading List

Document Date: 2011-05-20 13:45:43

Open Document

File Size: 177,54 KB

Share Result on Facebook

Company

HIPAA / Keene Corp. / Williams Bailey Law Firm L.L.P. / Arnold & Porter L.L.P. / Wyeth Corporation / American Home Products Corporation / Wyeth / /

Country

United States / /

Event

FDA Phase / Product Recall / Name Change / Product Issues / /

Facility

Mayo Clinic / /

IndustryTerm

ex parte communications / oral communications / cellular phone communications / treatment of obesity / /

MedicalCondition

obesity / valvular heart disease / associated valvular disease / /

MusicAlbum

July / /

Organization

New Jersey Supreme Court / United States Food & Drug Administration / COMMITTEE ON OPINIONS / Stempler Court / Congress / UN Court / SUPERIOR COURT OF NEW JERSEY / US Federal Reserve / American Medical Association / LAW DIVISION / Department of Health and Human Services / /

Person

Alex L. Bednar / Pamela L. Graber-Keith / NAIDA T. CATERINA / SHEILA M. ALLEN / INEZ E. BRYANT / Diane Kutzko / SHIRLEY A. WHITE / Linda Segal / PATRICIA GAUTHIER / SARAH ANN GIBSON / Marolyn J. Efird / LEA M. MORRISON / LINDA A. SEGAL / Anand Agneshwar / FRANKIE A. BRIGMAN / Drake L. Rev / Charlotte A. Hoffman / MARION F. SHOLAR / ELIZABETH W. WARD / Amy M. Carter / Tamela J. White / /

Position

counsel / physician / defense counsel / Secretary / /

Product

Pondimin / Pondimin® / Redux / Redux™ / /

ProvinceOrState

New Jersey / West Virginia / BERGEN COUNTY / North Carolina / /

PublishedMedium

the Journal of the American Medical Association / /

SocialTag